Hands, Sarah L <br/><br/>
Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.  [electronic resource] 

 -  Biochemical Society transactions  Apr 2010 
 - 552-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1470-8752 
<br/><br/><label>Standard No.: </label>10.1042/BST0380552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carrier Proteins--genetics<br/>Copper--metabolism<br/>Drug Delivery Systems<br/>Exons--genetics<br/>Gene Targeting<br/>HeLa Cells<br/>Homeostasis--genetics<br/>Humans<br/>Huntingtin Protein<br/>Huntington Disease--genetics<br/>Metabolic Networks and Pathways--genetics<br/>Metallothionein--metabolism<br/>Mutant Proteins--genetics<br/>Nerve Tissue Proteins--genetics<br/>Nuclear Proteins--genetics<br/>Protein Binding--genetics<br/>Saccharomyces<br/>Transfection